Market revenue in 2023 | USD 250.1 million |
Market revenue in 2030 | USD 638.4 million |
Growth rate | 14.3% (CAGR from 2023 to 2030) |
Largest segment | Reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents, Kits, Instruments, Enzymes, Services |
Key market players worldwide | Roche Holding AG, Thermo Fisher Scientific Inc, Eisai Co Ltd, Novartis AG ADR, Element Biosciences, Dovetail Genomics, Illumina Inc, Promega, Abcam PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epigenetics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 36.35% in 2023. Horizon Databook has segmented the Sweden epigenetics market based on reagents, kits, instruments, enzymes, services covering the revenue growth of each sub-segment from 2018 to 2030.
The epigenetics market in Sweden has been growing steadily over the past few years. This growth can be attributed to the increasing demand for gene editing technologies in R&D activities. Sweden ranked third among the European Union countries, with a share of 10.7% of the GDP spent on healthcare in 2023.
Major players in the epigenetics market in Sweden, such as Karolinska Institute, Svenska Cellulose AB (SCA), Nanozymes, & Crispr Therapeutics Sweden, are involved in the development of advanced gene editing technologies and the provision of related services.
These companies focus on developing innovative solutions to address the challenges associated with gene editing, such as off-target effects and low efficiency. The epigenetics market in Sweden is also witnessing growing demand for CRISPR/Cas9-based gene editing technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden epigenetics market , including forecasts for subscribers. This country databook contains high-level insights into Sweden epigenetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account